[EN] NIACIN DERIVATIVES USEFUL TO TREAT METABOLIC SYNDROMES<br/>[FR] DÉRIVÉS DE NIACINE UTILES POUR TRAITER DES SYNDROMES MÉTABOLIQUES
申请人:SCHERING CORP
公开号:WO2010009212A1
公开(公告)日:2010-01-21
The present invention provides compounds of the Formula I: (I) wherein R' represents a recoverable residue of a non-steroidal anti-inflammatory drug (NSAID); and G represents a hydrolysable or metabolizable linker group; and salts, solvates, esters and prodrugs thereof, as well as pharmaceutical compositions containing them, and methods of using them to treat metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastroenterological diseases, diabetes, and non-alcoholic fatty liver diseases.
本发明提供了公式I的化合物:(I),其中R'代表非甾体类抗炎药(NSAID)的可回收残基;G代表可水解或可代谢的连接基团;以及其盐,溶剂化合物,酯和前药,以及包含它们的制药组合物,并使用它们治疗代谢综合征,血脂异常,心血管疾病,外周和中枢神经系统疾病,血液系统疾病,癌症,炎症,呼吸系统疾病,胃肠疾病,糖尿病和非酒精性脂肪肝病的方法。